Divi's Laboratories Ltd.: Share Price, Stock Analysis, Annual Report | Value Research Get Divi's Laboratories Ltd.'s stock analysis, price valuation, corporate actions, and financials from India's independent mutual fund research house.
info-circle
DIVI'S LAB.

Click to see a quick summary and important updates about this stock!Dismiss

Divi's Laboratories Ltd.

BSE: 532488, NSE: DIVISLAB

  • Market Capitalisation info

    ₹98,784 Cr


  • 12 Month Earnings info

    ₹3,105 Cr

  • Price to Earnings info

    31.81

₹3,748.00

As on 16-Aug-2022 12:14 IST

up-down-arrow21.800.59%

  • Prev Close info

    3,726.20

  • Day's Openinfo

    3,790.00

  • Today's Highinfo

    3,790.00

  • Today's Lowinfo

    3,705.05

  • Today's Volumeinfo

    4,94,613

Please wait...

Stock Performance

YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
Divi's Laboratories
-19.88 0.54 -12.45 -24.26 34.75 42.45 20.71
S&P BSE Sensex
2.61 11.18 13.22 7.82 17.01 13.70 12.92
S&P BSE Healthcare
-11.40 2.78 4.04 -10.28 22.89 12.14 12.29
As on 16-Aug-2022
2021
2020
2019
2018
2017
2016
2015
Divi's Laboratories
21.54 111.23 25.10 34.90 40.15 -32.58 32.33
S&P BSE Sensex
21.99 15.75 14.38 5.87 27.91 1.95 -5.03
S&P BSE Healthcare
20.87 61.45 -3.55 -5.89 0.49 -12.88 15.06

Valuation

Stock
Peer Median

Growth & Efficiency

Stock
Peer Median

Solvency

Is there a threat to this company's solvency in the future?

Financial Manipulation

Can creative accounting be detected through the financial numbers?

Peer Comparison

search
search
search
search
    Please wait...

    Valuation Chart

      Please wait...
        Please wait...

        Financials

        Please wait...
        Please wait...
        Please wait...

        Shareholding Pattern

        News & Analysis

        Other Details

        Incorporated

        1990

        Chairman

        Ramesh BV Nimmagadda

        Managing Director

        Murali K Divi

        Group

        Divis Labs

        Headquarters

        Hyderabad, Telangana
        Edit edit
        Please wait...
        Please wait...
        Please wait...
        Please wait...

        Key Facts

        • Market cap info

          ₹98,783.51 Cr

        • Revenue (TTM) info

          ₹9,253.71 Cr

        • Earnings (TTM) info

          ₹3,105.35 Cr

        • Cash info

          ₹2,818.88 Cr

        • Total Debt info

          ₹0.00 Cr

        • Promoters' ownership info

          51.94%

        • Liquidity info

          High

        • 52 Week range info

          ₹3,365.55 - 5,425.10

        • Face value info

          ₹2.00

        • Shares outstanding info

          26,54,68,580

        • 10 Years Aggregate:

          CFO: ₹10,856.11 Cr

          EBITDA: ₹17,564.22 Cr

          Net Profit: ₹12,964.11 Cr

        About The Company

        • Business

          Manufacture of pharmaceuticals, medicinal chemical and botanical products

        • Incorporated

          1990

        • Chairman

          Ramesh BV Nimmagadda

        • Managing Director

          Murali K Divi

        • Group

          Divis Labs

        • Listing info

          BSE: 532488, NSE: DIVISLAB

        • Country

          India

        • Headquarters info

          Hyderabad, Telangana

        • Website info

          www.divislabs.com